INVESTORS PRISM PODCAST

Simplifying Vaccine Accessibility: Soligenix Advances Heat Stable Vaccine Candidates

October 5, 2021

Soligenix’s work in public health has become even more critical and timely as America moves through the Covid-19 pandemic, contemplating life where Covid might always be present, as well as preparing for the next potential pandemic. The company’s Covid vaccine candidate has demonstrated efficacy and broad neutralizing antibody responses against the original strain as well as Beta, Gamma and Delta variants of the virus in non-human primates. 

Podbean App

Play this podcast on Podbean App